CD8A and neoplasm: Studies have shown that chemotherapeutic agents can remove the suppressive effect of regulatory T cells (Tregs) (129), reduce the number of myeloid derived suppressor cells (MDSCs) (127) and increase CD8+ T cell activity resulting in a more effective anti-tumor immune response.